Eurofins Scientific SE
General ticker "ERFSF" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $14.1B (TTM average)
Eurofins Scientific SE follows the US Stock Market performance with the rate: 40.6%.
Estimated limits based on current volatility of 2.9%: low 68.49$, high 72.61$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-04-29, amount 0.68$ (Y0.94%)
Short-term ERFSF quotes
Long-term ERFSF plot
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | €6,951.00MM | €7,293.27MM |
| Operating Expenses | €6,224.80MM | €6,500.56MM |
| Operating Income | €726.20MM | €792.70MM |
| Non-Operating Income | €-171.60MM | €-138.95MM |
| Interest Expense | €150.80MM | €165.94MM |
| Income(Loss) | €554.60MM | €653.76MM |
| Taxes | €149.10MM | €180.93MM |
| Profit(Loss)* | €406.40MM | €474.82MM |
| Stockholders Equity | €5,339.00MM | €3,541.67MM |
| Inventory | €141.90MM | €138.95MM |
| Assets | €10,888.40MM | €10,980.89MM |
| Operating Cash Flow | €1,318.90MM | €1,294.51MM |
| Capital expenditure | €528.40MM | €759.72MM |
| Investing Cash Flow | €-846.50MM | €-1,086.59MM |
| Financing Cash Flow | €-1,089.50MM | €13.00MM |
| Earnings Per Share** | €2.13 | €2.64 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.